Inventor · disambiguated record
Irving W. Wainer
Also filed as: WAINER IRVING · WAINER IRVING W · WAINER IRVING WILLIAM
23 granted patents·21 pending applications·84 citations·filing 1996–2025
94Inventor score
Files withUS HEALTH14MITCHELL WOODS PHARMACEUTICALS INC5SPIRIFY PHARMA INC5WAINER IRVING W4THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC2
Top patents by PatentIndex Score
44 records- 0192US9867830B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2016·Granted Jan 16, 2018·12 cites·11 claims
- 0292US9650352B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painCOOPER HEALTH SYSTEM·Filed 2012·Granted May 16, 2017·27 cites·22 claims
- 0377US11111210B2Phenyl cyclohexanone derivatives and methods of making and using themSPIRIFY PHARMA INC·Filed 2016·Granted Sep 7, 2021·2 cites·20 claims
- 0477US2025319092A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2025·Application pending·0 cites
- 0575US10772849B2Methods of regulating cannabinoid receptor activity-related disorders and diseasesUS HEALTH·Filed 2019·Granted Sep 15, 2020·0 cites·13 claims
- 0675US9492405B2Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomasWAINER IRVING W·Filed 2011·Granted Nov 15, 2016·1 cites·6 claims
- 0771US11389415B2Methods of regulating cannabinoid receptor activity-related disorders and diseasesUS HEALTH·Filed 2020·Granted Jul 19, 2022·0 cites·14 claims
- 0870US10617654B2Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomasTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Apr 14, 2020·0 cites·18 claims
- 0968US10925840B2Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomasTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Feb 23, 2021·0 cites·15 claims
- 1068US2020360393A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 1166US10562843B2Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failureUS HEALTH·Filed 2019·Granted Feb 18, 2020·0 cites·20 claims
- 1265US10485771B2Methods of regulating cannabinoid receptor activity-related disorders and diseasesUS HEALTH·Filed 2018·Granted Nov 26, 2019·0 cites·14 claims
- 1364US10308591B2Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failureUS HEALTH·Filed 2018·Granted Jun 4, 2019·0 cites·4 claims
- 1463US9522871B2Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failureUS HEALTH·Filed 2014·Granted Dec 20, 2016·0 cites·1 claims
- 1563US7749984B2Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptorsUS HEALTH·Filed 2004·Granted Jul 6, 2010·1 cites·5 claims
- 1662US2024067611A1Phenyl cyclohexanone derivatives and methods of making and using themSPIRIFY PHARMA INC·Filed 2023·Application pending·0 cites
- 1761US2019076379A1Methods of treating breast cancerMITCHELL WOODS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1860US9908841B2Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failureUS HEALTH·Filed 2016·Granted Mar 6, 2018·0 cites·20 claims
- 1959US10130593B2Methods of regulating cannabinoid receptor activity-related disorders and diseasesUS HEALTH·Filed 2016·Granted Nov 20, 2018·0 cites·12 claims
- 2059US2018098993A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2017·Application pending·0 cites
- 2158US10130594B2Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomasUS HEALTH·Filed 2016·Granted Nov 20, 2018·0 cites·16 claims
- 2258US6387268B1Immobilization of membrane receptor on HPLCRETT CORP·Filed 2000·Granted May 14, 2002·6 cites·13 claims
- 2358US2015157580A1Methods of regulating cannabinoid receptor activity-related disorders and diseasesUS HEALTH·Filed 2013·Application pending·0 cites
- 2456US11827606B2Phenyl cyclohexanone derivatives and methods of making and using themSPIRIFY PHARMA INC·Filed 2021·Granted Nov 28, 2023·0 cites·18 claims
- 2555US5830672AElisa kit for the rapid determination of N-acetyltransferase (NAT2) phenotypesFiled 1996·Granted Nov 3, 1998·25 cites·16 claims
- 2655US2010168245A1Preparation of (r,r)-fenoterol and (r,r)-or (r,s)-fenoterol analogues and their use in treating congestive heart failureWAINER IRVING W·Filed 2007·Application pending·0 cites
- 2753US2023265046A1Hydroxynorketamine analogues, compositions comprising same and methods of use thereofSPIRIFY PHARMA INC·Filed 2021·Application pending·0 cites
- 2852US8703826B2Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failureWAINER IRVING W·Filed 2011·Granted Apr 22, 2014·0 cites·13 claims
- 2952US2023165811A1Method for treating symptoms of viral infectionsWAINER IRVING W·Filed 2021·Application pending·0 cites
- 3051US2017172945A1Methods of treating breast cancerMITCHELL WOODS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3146US2023181491A1Compositions and methods for the treatment and management of inflammation using hydroxynorketamineSPIRIFY PHARMA INC·Filed 2021·Application pending·0 cites
- 3244US6139735AImmobilization of membrane receptor on HPLCUNIV GEORGETOWN·Filed 1999·Granted Oct 31, 2000·9 cites·6 claims
- 3341US2018271808A1Methods of reducing chemoresistance and treating cancerMITCHELL WOODS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3441US2019083420A1Methods of using (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, fatigue, suicidal ideation, and post traumatic stress disordersUS HEALTH·Filed 2017·Application pending·0 cites
- 3541US2002125194A1Immobilization of membrane receptor on HPLCFiled 2002·Application pending·0 cites
- 3641US2003150812A1Novel parallel throughput systemFiled 2002·Application pending·0 cites
- 3740US2004053355A1Modular approach to on-line synthesis, drug discovery and biochemical transformations using immobilized enzyme reactorsFiled 2001·Application pending·0 cites
- 3840US2018042867A1Methods of treating cancerMITCHELL WOODS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3940US2017172944A1Methods of treating melanomaMITCHELL WOODS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4038US2003166301A1Multiple binding moiety chromatography device, methods of using and methods of making sameFiled 2002·Application pending·0 cites
- 4136US2004204862A1Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptorsFiled 2003·Application pending·0 cites
- 4233US2003006192A1Immobilized G-protein coupled receptors on liquid chromatography stationary phases and use thereof for on-line screeningFiled 2002·Application pending·0 cites
- 4330US5807926AImmobilized cofactor-dependent enzymesUNIV MCGILL·Filed 1996·Granted Sep 15, 1998·1 cites·19 claims
- 4421US6037337AUse of the enantiomers of ifosfamide in antitumor therapy for reducing side effectsDARWIN DISCOVERY LTD·Filed 1998·Granted Mar 14, 2000·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Irving W. Wainer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →